Back to
RENAISSANCE TECHNOLOGIES LLC
VIVO
Showing 0 of 15 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Renaissance Technologies held 2,100,304 shares of VIVO (Meridian Bioscience), worth $69.8M. Renaissance Technologies' 13F filings listed VIVO from Q3 2019 to Q4 2022, 14 quarterly filings. VIVO was 0.1% of Renaissance Technologies' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.